Chloe Walsh is a Commercial Forecasting Analyst at Commodore Capital. Prior to joining Commodore, she was an Engagement Manager at ClearView Healthcare Partners, where she conducted commercial due diligence for biotechnology investors and advised biopharmaceutical companies on corporate and commercial growth strategy.

Chloe earned her MBA from Columbia Business School, where she was a Feldberg Fellow. She also holds a MEng in Biomedical Engineering from Duke University and a BS in Finance and Biophysical Chemistry from William and Mary, where she graduated summa cum laude with Honors in Applied Science.

Chloe grew up in New Jersey and enjoys spending time with family and discovering new restaurants in the city.